Clinical trial
Antioxidant for Improvement of Hepatic Function in Patients With Alcohol Liver Disease Without Cirrhosis: Non-randomized Interventional Cohort Study
NCT03503708 is registered in ClinicalTrials.gov with Composite Interceptive Med Science as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antioxidant for Improvement of Hepatic Function in Patients With Alcohol Liver Disease Without Cirrhosis: Non-randomized Interventional Cohort Study
- Lead sponsor
- Composite Interceptive Med Science
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- May 30, 2018
- Completion date
- November 30, 2028
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcoholic liver disease